REVLANTE Trademark

Trademark Overview


On Thursday, August 7, 2014, a trademark application was filed for REVLANTE with the United States Patent and Trademark Office. The USPTO has given the REVLANTE trademark a serial number of 79153436. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, April 9, 2018. This trademark is owned by NOVARTIS AG. The REVLANTE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics
revlante

General Information


Serial Number79153436
Word MarkREVLANTE
Filing DateThursday, August 7, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, April 9, 2018
Registration Number4697842
Registration DateTuesday, March 10, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 23, 2014

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention or treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, April 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, March 21, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 17, 2020CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Friday, March 1, 2019NOTIFICATION PROCESSED BY IB
Thursday, December 20, 2018CORRECTION TRANSACTION RECEIVED FROM IB
Friday, November 2, 2018NOTIFICATION PROCESSED BY IB
Friday, April 27, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, April 27, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, June 5, 2015NOTIFICATION PROCESSED BY IB
Wednesday, May 20, 2015FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 20, 2015FINAL DISPOSITION PROCESSED
Thursday, April 9, 2015GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, March 10, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, December 23, 2014PUBLISHED FOR OPPOSITION
Friday, December 19, 2014NOTIFICATION PROCESSED BY IB
Wednesday, December 3, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 3, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 3, 2014NOTICE OF PUBLICATION
Thursday, November 13, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 12, 2014ASSIGNED TO EXAMINER
Saturday, October 25, 2014APPLICATION FILING RECEIPT MAILED
Tuesday, October 21, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 20, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, October 16, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB